Fragment, CJC-1295 (No DAC), Ipamorelin 12mg (Blend)

Fragment, CJC-1295 (no DAC), and Ipamorelin is a research peptide blend combining hGH Fragment 176–191 with GHRH and ghrelin receptor agonists for coordinated growth hormone axis modeling. The fragment modulates AMPK and β-adrenergic signaling, CJC-1295 (Mod GRF 1–29) activates GHRH receptor pathways, and Ipamorelin stimulates calcium-dependent GHS-R1a signaling. This blend supports research into metabolic peptide synergy and hypothalamic–pituitary function.